The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with ...
The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab ...
The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today positive data for Olumiant® (baricitinib) will be presented at ...
The FINANCIAL -- Lilly reported Q3 financial results: - Revenue in the third quarter of 2020 increased 5 percent driven ...
THe FINANCIAL -- Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company ...
The FINANCIAL -- Lilly is creating and testing neutralizing antibodies that target the viral spike protein that SARS-CoV-2 uses to gain entry ...
